Human anti-CD47 antibodies and uses thereof
US11390677B2 · kind B2 · utility
0Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2019 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Mar 12, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antibodies that bind to CD47 with high affinity and specificity, and their use in treatment of a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.